Assistant Professor of Medicine, University Tex San Antonio
Hematology
Dr. Paul J. Shaughnessy, MD
|
|
Give Review
Paul J. Shaughnessy is an expert in the field of Hematology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He has 1 awards "Top Doctors:SE Texas". Paul Shaughnessy is also a published doctor. He has 30 paper published. The most recent paper is: Tbo-Filgrastim versus Filgrastim during Mobilization andNeutrophil Engraftment for Autologous Stem CellTransplantation. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.
- Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed Multiple myeloma undergoing a second autologous blood...
- Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines of the American Society for Blood and Marrow...
- Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations.
- Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guid...
- Outcomes and costs of autologous stem Cell mobilization with chemotherapy plus G-CSF vs G-CSF alone.
- Pharmacoeconomics of hematopoietic stem Cell mobilization: an overview of current evidence and gaps in the literature.
- G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem Cells in patients with thrombocytopenia or leukopenia prior to auto-SCT.
- Plerixafor and G-CSF for autologous stem Cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.
- Once daily busulfan cyclophosphamide is well tolerated and effective as a preparative regimen for allogeneic hematopoietic stem Cell transplant.
- Comparison of short-term response and long-term outcomes after initial systemic treatment of Chronic graft-versus-host disease.
- Evaluation of mycophenolate mofetil for initial treatment of Chronic graft-versus-host disease.
- Granulocyte colony-stimulating factor mobilizes more dendritic Cell subsets than granulocyte-macrophage colony-stimulating factor with no polarization of dendritic cel...
- Denileukin diftitox for the treatment of steroid-resistant Acute graft-versus-host disease.
- Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem Cell transplantation for hematologic diseases: the Texas Transplant Co...
- Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic ...
- Extracorporeal photopheresis for the prevention of Acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transpl...
- Cost and clinical analysis of autologous hematopoietic stem Cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide.
- Expression of adhesion molecules on CD34(+) Cells in peripheral blood of non-hodgkin's lymphoma patients mobilized with different growth factors.
- Peripheral blood stem Cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: a rando...
- Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem Cell rescue.
- Mobilization of dendritic Cells and NK Cells in non-Hodgkin's lymphoma patients mobilized with different growth factors.
- Differential mobilization of CD34+ Cells and lymphoma Cells in non-Hodgkin's lymphoma patients mobilized with different growth factors.
- Ancillary therapy and supportive care of Chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials...
- A phase II trial with gemcitabine and paclitaxel for the treatment of refractory and relapsed Multiple myeloma patients.
- Allogeneic hematopoietic stem Cell transplantation in the active duty military population: 1987-2001.
- Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma Cells is not blocked by BCL-2.
- Correlation of CD34+ Cell counts with volume of bone marrow collected for allogeneic bone marrow harvests.
- Allogeneic bone marrow transplantation at Wilford Hall U.S. Air Force Medical Center: 1987-1999.
Schools
Indiana University School Of Medicine
Wilford Hall Medical Center
Wilford Hall Mc
Indiana University
Procedures Preformed
- Autologous Stem Cell Transplant for Hematologic Malignancy
- Blood Transfusion
- Bone Marrow Transplant
- Catheterization
- View All
Conditions Treated
- Acute Leukemia
- Anemia
- Aplastic Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Medical Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- GEHA
- HealthSmart
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- Molina
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Top Doctors:SE Texas
Education
-
San Antonio Uniformed Services Health Education Consortium -
Indiana University School of Medicine
Drug Facts
| NPI NUMBER | 1316904550 | |
| NPPES Provider LastName | SHAUGHNESSY | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 782293902 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology | |
| Total Claim Count | 672.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 22.0 | |
| Percent Opioid Claims | 3.27 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316904550 |
| Last Name Of The Provider | SHAUGHNESSY |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
Dr. Carlos R. Bachier, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrew J. Brenner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl R. Meier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony W. Tolcher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse E. Medellin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rogelio I. Gonzalez, MD |
|
|
Dr. Devalingam Mahalingam, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Francis J. Giles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Wiggins, MD |